Cliff Asness's NVCT Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 31,886 shares of Nuvectis Pharma, Inc. (NVCT) worth $586,385, representing 0.00% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Cliff Asness has initiated a new position in NVCT, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Nuvectis Pharma (NVCT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Nuvectis Pharma (NVCT) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +31,886 | New Buy | 31,886 | $18.39 |
Cliff Asness's Nuvectis Pharma Investment FAQs
Cliff Asness first purchased Nuvectis Pharma, Inc. (NVCT) in Q2 2026, acquiring 31,886 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Nuvectis Pharma, Inc. (NVCT) for 1 quarters since Q2 2026.
Cliff Asness's largest addition to Nuvectis Pharma, Inc. (NVCT) was in Q2 2026, adding 31,886 shares worth $586,385.
According to the latest 13F filing for Q2 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 31,886 shares of Nuvectis Pharma, Inc. (NVCT), valued at approximately $586,385.
As of the Q2 2026 filing, Nuvectis Pharma, Inc. (NVCT) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Nuvectis Pharma, Inc. (NVCT) was 31,886 shares, as reported at the end of Q2 2026.